Effect of exercise intensity on renal blood flow in patients with chronic kidney disease stage 2.


Journal

Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923

Informations de publication

Date de publication:
May 2019
Historique:
received: 20 05 2018
accepted: 25 12 2018
pubmed: 8 2 2019
medline: 10 9 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

Acute exercise reduces renal blood flow (RBF). However, the effect of exercise intensity on RBF in patients with chronic kidney disease (CKD) stage 2 is not known. We investigated the association between RBF and exercise intensity in patients with CKD stage 2 using pulsed Doppler ultrasonography. Eight men with CKD stage 2 (cystatin C-based estimate of glomerular filtration rate: 60-89 ml/min/1.73 m Renal blood flow after the MGET was 52% lower than at rest, and did not recover as well as after the exercise test. Cross-sectional area (CSA) was significantly lower after graded exercise. RBF tended to be lower at 100% of LT and was significantly lower at 120% of LT. CSA was significantly lower at 100% of LT. Renal blood flow does not change during exercise until the LT is reached. These findings may assist in making appropriate exercise recommendations to patients with CKD stage 2.

Sections du résumé

BACKGROUND BACKGROUND
Acute exercise reduces renal blood flow (RBF). However, the effect of exercise intensity on RBF in patients with chronic kidney disease (CKD) stage 2 is not known. We investigated the association between RBF and exercise intensity in patients with CKD stage 2 using pulsed Doppler ultrasonography.
METHODS METHODS
Eight men with CKD stage 2 (cystatin C-based estimate of glomerular filtration rate: 60-89 ml/min/1.73 m
RESULTS RESULTS
Renal blood flow after the MGET was 52% lower than at rest, and did not recover as well as after the exercise test. Cross-sectional area (CSA) was significantly lower after graded exercise. RBF tended to be lower at 100% of LT and was significantly lower at 120% of LT. CSA was significantly lower at 100% of LT.
CONCLUSIONS CONCLUSIONS
Renal blood flow does not change during exercise until the LT is reached. These findings may assist in making appropriate exercise recommendations to patients with CKD stage 2.

Identifiants

pubmed: 30729347
doi: 10.1007/s10157-018-01685-3
pii: 10.1007/s10157-018-01685-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-628

Références

Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–163.
doi: 10.1007/s10157-007-0463-x pubmed: 17593516
Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.
doi: 10.1007/s10157-014-0949-2
Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–95.
doi: 10.1681/ASN.2004030203 pubmed: 15590763
Michishita R, Matsuda T, Kawakami S, Kiyonaga A, Tanaka H, Morito N, Higaki Y. The association between unhealthy lifestyle behaviors and the prevalence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol. 2016;26:378–85.
doi: 10.2188/jea.JE20150202 pubmed: 26947951
Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4:1901–6.
doi: 10.2215/CJN.01970309 pubmed: 19820134 pmcid: 2798872
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura MK, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.
doi: 10.1053/j.ajkd.2014.01.416 pubmed: 24647050
National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850–86.
doi: 10.1053/j.ajkd.2012.07.005
Poortsmans JR. Exercise and renal function. Sports Med. 1984;1:125–53.
doi: 10.2165/00007256-198401020-00003
Castenfors J. Renal function during exercise. Acta Physiol Scand. 1967;70(Suppl. 293):1–44.
Castenfors J. Renal function during prolonged exercise. Ann N Y Acad Sci. 1977;301:151–9.
doi: 10.1111/j.1749-6632.1977.tb38194.x pubmed: 270912
Grimby G. Renal clearances during prolonged supine exercise at different loads. J Appl Physiol. 1965;20:1294–8.
doi: 10.1152/jappl.1965.20.6.1294
Suzuki M. Physical exercise and renal function. J Phys Fit Sports Med. 2015;4:17–29.
doi: 10.7600/jpfsm.4.17
Kawakami S, Yasuno T, Matsuda T, Fujimi K, Ito A, Yoshimura S, Uehara Y, Tanaka H, Saito T, Higaki Y. Association between exercise intensity and renal blood flow evaluated using ultrasound echo. Clin Exp Nephrol. 2018. https://doi.org/10.1007/s10157-018-1559-1 (Epub ahead of print).
doi: 10.1007/s10157-018-1559-1 pubmed: 29525855
Johansen KL. Exercise and chronic kidney disease current recommendations. Sport Med. 2005;35:485–99.
doi: 10.2165/00007256-200535060-00003
Kirkman D, Edwards DG, Lennon-Edwards S. Exercise as an adjunct therapy in chronic kidney disease. Renal Nutr Forum. 2014;33:1–8.
pubmed: 26069463 pmcid: 4461233
Johansen KL, Painter P. Exercise in individuals with CKD. Am J Kidney Dis. 2012;59:126–34.
doi: 10.1053/j.ajkd.2011.10.008 pubmed: 22113127
Momen A, Leuenberger UA, Ray CA, Cha S, Handly B, Sinoway LI. Renal vascular responses to static handgrip: role of muscle mechanoreflex. Am J Physiol Heart Circ Physiol. 2003;285:H1247–53.
doi: 10.1152/ajpheart.00214.2003 pubmed: 12750063
Momen A, Bower D, Leuenberger UA, Boehmer J, Lerner S, Alfrey EJ, Handly B, Sinoway LI. Renal vascular response to static handgrip exercise: sympathetic vs. autoregulatory control. Am J Physiol Heart Circ Physiol. 2005;289:H1770–6.
doi: 10.1152/ajpheart.01213.2004 pubmed: 15951339
Endo MY, Suzuki R, Nagahata N, Hayashi N, Miura A, Koga S, Fukuba Y. Differential arterial blood flow response of splanchnic and renal organs during low-intensity cycling exercise in women. Am J Physiol Heart Circ Physiol. 2008;294:H2322–6.
doi: 10.1152/ajpheart.91491.2007 pubmed: 18344373
Lesley AS, Josef C, Christopher HS, Harold IF, Marc F, John K, Jerome R, Frederick VL, Robert DB, Yaping Z, Tom G, Andrew SL. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406.
doi: 10.1053/j.ajkd.2007.11.018
Horio M, Imai E, Yasuda Y, Matsuo S, et al. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61(2):197–203.
doi: 10.1053/j.ajkd.2012.07.007
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.
doi: 10.1053/j.ajkd.2008.12.034
Suzuki M. Exercise and renal function. Adv Ex Sports Physiol. 1996;2:45–56.
Ueda J, Nakanishi H, Miyazaki M. Effects of glucagon on the renal hemodynamics of dogs. Jpn Circ J. 1977;41:991–6.
doi: 10.1253/jcj.41.991 pubmed: 916158
Monika JB, et al. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol. 2014;170:529–38.
doi: 10.1530/EJE-13-0941
Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335–47.
doi: 10.1093/ajh/1.4.335
Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612–9.
doi: 10.1172/JCI112013 pubmed: 2993362 pmcid: 423867
Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, Ikeda M, Arakawa K. Effect of acute exercise on plasma immunoreactive—Atrial natriuretic factor. Life Sci. 1986;39:1685–93.
doi: 10.1016/0024-3205(86)90166-9 pubmed: 2945977
Sanders LR. Exercise-induced acute renal failure associated with ibuprofen, hydrochlorothiazide, and triamterene. J Am Soc Nephrol. 1995;5:2020–3.
pubmed: 7579049

Auteurs

Kazuko Kotoku (K)

Graduate School of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
Faculty of Medicine and Health Science, Yamaguchi University, 1-1-1, Minamiogushi, Ube, Yamaguchi, 755-8505, Japan.

Tetsuhiko Yasuno (T)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0133, Japan.

Shotaro Kawakami (S)

Department of Rehabilitation, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikushino, Fukuoka, 818-0067, Japan.

Kanta Fujimi (K)

Department of Rehabilitation, Fukuoka University Hospital, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0133, Japan.

Takuro Matsuda (T)

Department of Rehabilitation, Fukuoka University Hospital, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0133, Japan.

Shihoko Nakashima (S)

Laboratory of Exercise Physiology, Faculty of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.

Yoshinari Uehara (Y)

Laboratory of Exercise Physiology, Faculty of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
Fukuoka University Institute for Physical Activity, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.

Hiroaki Tanaka (H)

Laboratory of Exercise Physiology, Faculty of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
Fukuoka University Institute for Physical Activity, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.

Takao Saito (T)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0133, Japan.

Yasuki Higaki (Y)

Laboratory of Exercise Physiology, Faculty of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan. higaki@fukuoka-u.ac.jp.
Fukuoka University Institute for Physical Activity, 8-19-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan. higaki@fukuoka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH